Financial

Cardiovascular Systems, Inc. Announces Stephen Stenbeck Joins Board of Directors

Brent Blackey Retires after 12 Years of Service ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Stephen Stenbeck. He replaces independent director […]

Milestone Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Corporate Update

– NODE-301 topline data readout expected in mid-1H20 – – Richard Pasternak, M.D. appointed to the Company’s Board of Directors – MONTREAL and CHARLOTTE, N.C., Nov. 13, 2019 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today reported financial results for the third […]

Neovasc Announces Third Quarter 2019 Financial Results

Recent Highlights ·         Delivered continued revenue growth for Neovasc ReducerTM (“Reducer”) ·         Reducer added to the European Society of Cardiology Practice Guidelines for the treatment of refractory angina ·         Reducer featured at the 40th Annual National Congress of the Italian Society of Interventional Cardiology ·         Announced Norman Radow joined the board of directors ·         Granted a […]

Shockwave Medical Reports Third Quarter 2019 Financial Results

SANTA CLARA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended September 30, 2019. Recent Highlights Recognized revenue of $11.3 million […]

Neovasc Appoints Cardiovascular Industry Veteran Bill Little as Chief Operating Officer

Vancouver, Nov. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced the appointment of Bill Little […]

ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update

PRECISION-AF pivotal Phase 3 clinical trial initiation anticipated first quarter of 2020 Trial to examine atrial fibrillation in a heart failure population for which there are no FDA indicated drug therapies WESTMINSTER, Colo., Nov. 06, 2019 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach […]